Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2020 for AKCEA THERAPEUTICS, INC., €327.6M. Read the official filing
Filing timeline
BuySaleIonis Pharmaceuticals Inc
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ionis Pharmaceuticals Inc: trading record in brief
Ionis Pharmaceuticals Inc is a declared insider of Akcea Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 19 July 2017 and 10 October 2020, the trades on record add up to 10 filings.
No open-market sale appears; the market trades are 3 purchases worth €510.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €161.6M. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 14 October 2020: an open-market purchase of €327.6M, in Akcea Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ionis Pharmaceuticals Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
21,237,715 shares@ US$18.15100.0% of flowCommon StockSEC:0000899243-20-028167:0
Canonical exit: 8 Jan 2021 (T+90)
6,873,344 sharesCommon StockSEC:0001209191-19-061304:0
2,837,373 sharesCommon StockSEC:0001209191-19-022439:0
1,671,849 sharesCommon StockSEC:0001209191-18-055607:0
1,597,571 sharesCommon StockSEC:0001209191-18-045573:0
8,000,000 sharesCommon StockSEC:0001209191-18-025646:0
10,666,666 shares@ US$18.7531.6% of flowCommon StockSEC:0001209191-18-025646:1
Canonical exit: 16 Jul 2018 (T+90)
3,125,000 shares@ US$8.004.2% of flowCommon StockSEC:0001209191-17-045915:2
Canonical exit: 17 Oct 2017 (T+90)
13,438,339 sharesCommon StockSEC:0001209191-17-045915:1
28,884,540 sharesCommon StockSEC:0001209191-17-045915:0
10 of 10 declarations
